Scott Biller - 21 Jun 2022 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Director
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
Issuer symbol
FHTX
Transactions as of
21 Jun 2022
Transactions value $
$0
Form type
4
Filing time
22 Jun 2022, 21:00:49 UTC
Previous filing
14 Jul 2021
Next filing
22 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Options (Right to buy) Award $0 +16,000 $0 16,000 21 Jun 2022 Common Stock 16,000 $13.81 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.